Skip to main content
. Author manuscript; available in PMC: 2021 Feb 12.
Published in final edited form as: Transfusion. 2014 Nov 5;55(4):709–718. doi: 10.1111/trf.12918

TABLE 3.

Imputability and severity designations of transfusion-related adverse reactions reported to the NHSN Hemovigilance Module, United States, 2010 to 2012

Adverse reaction Number (%) Imputability (n = 5136)
Severity (n = 5136)
Definite Probable Possible Nonsevere Severe Life-threatening Fatal Not determined
Allergic 2406 (46.8) 1481   735 190 2232 160 12 0   2
FNHTR 1853 (36.1)   670   598 585 1829   18   0 0   6
DSTR 321 (6.3)   321   302  3   0 0 16
TACO 196 (3.8)  67  85   44   123   59 13 0   1
Hypotensive 136 (2.6)  32  55   49   102   28   6 0   0
DHTR 90 (1.8)  67  16  7  69   17   0 0   4
TAD 72 (1.4)  21  24   27  54   11   6 0   1
TRALI 26 (0.5)    6   20    4   15   4 3   0
AHTR 24 (0.5)  15    7  2  12   10   2 0   0
TTI 12 (0.2)    6    2  4    3  8   0 1   0
Total (%) 5136 (100) 2686 (52.3) 1522 (29.6) 928 (18.1) 4730 (92.1) 329 (6.4)   43 (0.8) 4 (0.1)   30 (0.6)

AHTR = acute hemolytic transfusion reaction; DHTR = delayed hemolytic transfusion reaction; DSTR = delayed serologic transfusion reaction; FNHTR = febrile nonhemolytic transfusion reaction; TACO = transfusion-associated circulatory overload; TAD = transfusion-associated dyspnea; TRALI = transfusion-related acute lung injury; TTI = transfusion-transmitted infection.